Cargando…
Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach
Major depressive disorder (MDD) is one of the most common psychiatric disorders that accompany psychophysiological and mood changes. However, the pathophysiology-based disease mechanism of MDD is not yet fully understood, and diagnosis is also conducted through interviews with clinicians and patient...
Autores principales: | Lee, Seungyeon, Mun, Sora, Lee, You-Rim, Choi, Hyebin, Joo, Eun-Jeong, Kang, Hee-Gyoo, Lee, Jiyeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707625/ https://www.ncbi.nlm.nih.gov/pubmed/36458116 http://dx.doi.org/10.3389/fpsyt.2022.1002828 |
Ejemplares similares
-
Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021) -
Validation of the Metabolite Ergothioneine as a Forensic Marker in Bloodstains
por: Lee, Seungyeon, et al.
Publicado: (2022) -
Serum Protein Profiling Reveals a Decrease in Apolipoprotein A-IV During a Clinical Depressive Mood State
por: Mun, Sora, et al.
Publicado: (2023) -
L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder
por: Nie, Li-Juan, et al.
Publicado: (2021) -
Serum biomarker discovery related to pathogenesis in acute coronary syndrome by proteomic approach
por: Shin, Miji, et al.
Publicado: (2021)